AAA or AAA+ (ATPases Associated with diverse cellular Activities) proteins couple chemical energy provided by ATP hydrolysis to the remodeling or translocation of macromolecules. They are involved in a wide range of cellular processes, including DNA replication, protein degradation, membrane fusion, microtubule severing, peroxisome biogenesis, signal transduction and the regulation of gene expression.

1. Dikoglu E, Alfaiz A, Gorna M, Bertola D, Chae JH, Cho TJ, Derbent M, Alanay Y, Guran T, Kim OH et al.. (2015) Mutations in LONP1, a mitochondrial matrix protease, cause CODAS syndrome. Am J Med Genet A, 167 (7): 1501-9. [PMID:25808063]

2. Huang J, Zhang J, Luo B, Qiao W, Qiu Z, Song R, Dai Z, Sui J, Xu X, Ruan S et al.. (2022) Discovery of a Novel Series of Imipridone Compounds as Homo sapiens Caseinolytic Protease P Agonists with Potent Antitumor Activities In Vitro and In Vivo. J Med Chem, 65 (11): 7629-7655. [PMID:35609303]

3. Kang SG, Dimitrova MN, Ortega J, Ginsburg A, Maurizi MR. (2005) Human mitochondrial ClpP is a stable heptamer that assembles into a tetradecamer in the presence of ClpX. J Biol Chem, 280 (42): 35424-32. [PMID:16115876]

4. Kang SG, Ortega J, Singh SK, Wang N, Huang NN, Steven AC, Maurizi MR. (2002) Functional proteolytic complexes of the human mitochondrial ATP-dependent protease, hClpXP. J Biol Chem, 277 (23): 21095-102. [PMID:11923310]

5. Kingsley LJ, He X, McNeill M, Nelson J, Nikulin V, Ma Z, Lu W, Zhou VW, Manuia M, Kreusch A et al.. (2021) Structure-Based Design of Selective LONP1 Inhibitors for Probing In Vitro Biology. J Med Chem, 64 (8): 4857-4869. [PMID:33821636]

6. Nie X, Li M, Lu B, Zhang Y, Lan L, Chen L, Lu J. (2013) Down-regulating overexpressed human Lon in cervical cancer suppresses cell proliferation and bioenergetics. PLoS One, 8 (11): e81084. [PMID:24260536]

7. Peter B, Waddington CL, Oláhová M, Sommerville EW, Hopton S, Pyle A, Champion M, Ohlson M, Siibak T, Chrzanowska-Lightowlers ZMA et al.. (2018) Defective mitochondrial protease LonP1 can cause classical mitochondrial disease. Hum Mol Genet, 27 (10): 1743-1753. [PMID:29518248]

8. Pinti M, Gibellini L, Nasi M, De Biasi S, Bortolotti CA, Iannone A, Cossarizza A. (2016) Emerging role of Lon protease as a master regulator of mitochondrial functions. Biochim Biophys Acta, 1857 (8): 1300-1306. [PMID:27033304]

9. Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, Jhaveri A, Ferrarini I, Lee Y, Parker C et al.. (2020) ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. Neoplasia, 22 (12): 725-744. [PMID:33142238]

10. Quirós PM, Español Y, Acín-Pérez R, Rodríguez F, Bárcena C, Watanabe K, Calvo E, Loureiro M, Fernández-García MS, Fueyo A et al.. (2014) ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity. Cell Rep, 8 (2): 542-56. [PMID:25017063]